0001739614-21-000039.txt : 20210218
0001739614-21-000039.hdr.sgml : 20210218
20210218170649
ACCESSION NUMBER: 0001739614-21-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wagner Klaus W.
CENTRAL INDEX KEY: 0001766477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39452
FILM NUMBER: 21650483
MAIL ADDRESS:
STREET 1: C/O INHIBRX, INC.
STREET 2: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibrx, Inc.
CENTRAL INDEX KEY: 0001739614
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 824257312
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 795-4220
MAIL ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
wf-form4_161368598906751.xml
FORM 4
X0306
4
2021-02-16
0
0001739614
Inhibrx, Inc.
INBX
0001766477
Wagner Klaus W.
C/O INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
1
0
0
Chief Medical Officer
Common Stock
2021-02-16
4
S
0
156474
24.32
D
234709
D
Common Stock
2021-02-17
4
S
0
19559
25.29
D
215150
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan on September 14, 2020.
The shares were sold in multiple transactions at prices ranging from $22.14 to $32.50, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $25.00 to $25.50, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
/s/ Kelly D. Deck, attorney-in-fact
2021-02-18